Fibrosis Lessens After Metabolic Surgery

Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD); Non-Alcoholic Fatty Liver Disease; Metabolic Dysfunction-Associated Steatohepatitis (MASH); Liver Fibrosis; Obesity Interventions: Procedure: Metabolic surgery; Drug: Incretin-Based Therapy Sponsors: Ali Aminian Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials